Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Terry Box

Gastroenterology Salt Lake City, UT Medical Doctor

NPI 1235142985 CMS profile 426843

30 N 1900 E, 4R118 Som, Salt Lake City, UT 84132

Open in the dashboard

General payments

$301,759

313 records reported · program years 2019–2025

Research payments

$500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Terry Box of Salt Lake City, UT is reported in the CMS Open Payments database as having received $301,759 across 313 general payments and $500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $74,046 80
2024 General $79,152 71
2023 General $19,230 28
2022 General $23,043 25
2022 Research $500 1
2021 General $42,979 38
2020 General $22,495 33
2019 General $40,813 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Terry Box
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Terry Box were reported at $74,046. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Terry Box Gastroenterology median Middle half National median
2019 $40,813 $417 $126–$1,100 $163
2020 $22,495 $224 $74–$624 $114
2021 $42,979 $352 $106–$1,054 $132
2022 $23,043 $448 $129–$1,270 $149
2023 $19,230 $533 $150–$1,390 $160
2024 $79,152 $605 $160–$1,606 $164
2025 $74,046 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Gilead Sciences, Inc. $192,239 198 payments
  2. Intercept Pharmaceuticals, Inc. $84,224 84 payments
  3. AbbVie, Inc. $19,757 24 payments
  4. Mallinckrodt Hospital Products Inc. $5,000 1 payment
  5. Eisai Inc. $187 2 payments
  6. Terumo Medical Corporation $147 1 payment
  7. FUJIFILM Wako Diagnostics U.S.A. Corporation $126 1 payment
  8. GlaxoSmithKline, LLC. $57 1 payment
  9. Madrigal Pharmaceuticals $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $163,326 54 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $43,340 13 payments
  3. Travel and Lodging $37,069 109 payments
  4. Consulting Fee $27,000 7 payments
  5. Honoraria $15,526 11 payments
  6. Food and Beverage $8,098 117 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,400 2 payments
Products named General payments · program years 2019–2025
  1. Livdelzi $73,768 60 payments
  2. Epclusa $53,324 57 payments
  3. OCALIVA Hepatology / Gastroenterology $32,945 29 payments
  4. OCALIVA Hepatology Gastroenterology $30,730 29 payments
  5. MAVYRET $19,757 24 payments
  6. Azur CX Detachable $293 2 payments
  7. NAVICROSS $147 1 payment
  8. Wako HCC Biomarker(s) DCP and AFP-L3 $126 1 payment
  9. Lenvima $122 1 payment
  10. Vemlidy $122 1 payment
  11. Other $24 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Intercept Pharmaceuticals, Inc. $500 1 payment

Records

314 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record